L, Z., Y, L., T, C., J, C., H, Y., X, W., . . . C, P. (2021). Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma. Dove Medical Press.
Cita Chicago Style (17a ed.)L, Zhang, Luo Y, Cheng T, Chen J, Yang H, Wen X, Jiang Z, Li H, y Pan C. Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma. Dove Medical Press, 2021.
Cita MLA (8a ed.)L, Zhang, et al. Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.